The role of new oral anticoagulants in orthopaedics: an update of recent evidence.

about

The role of new oral anticoagulants in orthopaedics: an update of recent evidence.

Item

http://www.wikidata.org/entity/Q39185541

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The role of new oral anticoagulants in orthopaedics: an update of recent evidence.

@en

The role of new oral anticoagulants in orthopaedics: an update of recent evidence.

@nl

type

Item

label

The role of new oral anticoagulants in orthopaedics: an update of recent evidence.

@en

The role of new oral anticoagulants in orthopaedics: an update of recent evidence.

@nl

prefLabel

The role of new oral anticoagulants in orthopaedics: an update of recent evidence.

@en

The role of new oral anticoagulants in orthopaedics: an update of recent evidence.

@nl

P1476

The role of new oral anticoagulants in orthopaedics: an update of recent evidence.

@en

P2093

Anastasios V Korompilias

http://www.w3.org/2001/XMLSchema#string

Andreas G Tsantes

http://www.w3.org/2001/XMLSchema#string

Dimitrios V Papadopoulos

http://www.w3.org/2001/XMLSchema#string

Ioannis Gkiatas

http://www.w3.org/2001/XMLSchema#string

Ioannis Kostas-Agnantis

http://www.w3.org/2001/XMLSchema#string

Panagiota Ziara

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Novel antidotes for target specific oral anticoagulants

Management of the bleeding patient receiving new oral anticoagulants: a role for prothrombin complex concentrates

The use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery

Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons

Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials.

New oral pharmacotherapeutic agents for venous thromboprophylaxis after total hip arthroplasty

Edoxaban: an update on the new oral direct factor Xa inhibitor.

Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.

Apixaban or enoxaparin for thromboprophylaxis after knee replacement.

P2888

s00590-017-1940-x

P304

573-582

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00590-017-1940-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28314985

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation